A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
收藏官方服务：
资源简介：
24-week study to evaluate the efficacy and safety of macitentan for the treatment of portopulmonary hypertension.
提供机构：
Vivli创建时间：
2022-04-22
